Leunz Cadely
Psychiatric/Mental Health · Brooklyn, NYNPI 1053940064
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.2% of the total across 144 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 15 manufacturers reported payments, led by Johnson & Johnson at 26.0% of the total. Among psychiatric/mental health clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 144 payments — averaging $90.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$3K
- Neurocrine Biosciences, Inc.$2K
- Teva Pharmaceuticals USA, Inc.$2K
- Alkermes, Inc.$1K
- Otsuka America Pharmaceutical, Inc.$1K
- AbbVie$1K
- plus $3K from 9 others
What the payments were for
- Food & beverage$12,98799%
- Education$1001%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 29 | $3,406 |
| Neurocrine Biosciences, Inc. | 16 | $1,654 |
| Teva Pharmaceuticals USA, Inc. | 14 | $1,578 |
| Alkermes, Inc. | 23 | $1,453 |
| Otsuka America Pharmaceutical, Inc. | 25 | $1,383 |
| AbbVie | 13 | $1,068 |
| E.r. Squibb & Sons, L.L.C. | 7 | $889 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 5 | $618 |
| Vanda Pharmaceuticals Inc. | 4 | $472 |
| Idorsia Pharmaceuticals US Inc | 2 | $147 |
| Luye Pharma (USA) Ltd. | 1 | $130 |
| Bioxcel Therapeutics, Inc. | 1 | $122 |
| Eisai Inc. | 1 | $97 |
| Lundbeck LLC | 2 | $57 |
| Indivior Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INVEGA SUSTENNA$3,005
- LYBALVI$2,407
- ARISTADA$1,863
- INGREZZA$1,545
- VRAYLAR$893
- COBENFY$764
- CAPLYTA$618
- AUSTEDO$618
- UZEDY$610
- REXULTI$500
- Fanapt$472
- ARISTADA INITIO$466
- INVEGA TRINZA$395
- ABILIFY MAINTENA$368
- Austedo XR$250
- ABILIFY ASIMTUFII$243
- SPRAVATO$142
- ERZOFRI EXTENDED-RELEASE$130
- QUVIVIQ$125
- IGALMI$122
How this compares
$13,087 in reported general payments places this provider in the 95th percentile of 2,385 psychiatric/mental health providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Invega SustennaPaliperidone Palmitate | 13 | $38,798 |
| Chlorpromazine Hcl | 13 | $7,292 |
| Paliperidone ErPaliperidone | 14 | $4,945 |
| Aripiprazole | 30 | $1,144 |
| Clozapine | 17 | $940 |
| Divalproex Sodium | 36 | $707 |
| Divalproex Sodium ErDivalproex Sodium | 35 | $613 |
| Haloperidol | 27 | $512 |
| Quetiapine Fumarate | 37 | $468 |
| Bupropion XlBupropion Hcl | 21 | $260 |
| Risperidone | 20 | $221 |
| Benztropine Mesylate | 14 | $180 |
| Lithium Carbonate ErLithium Carbonate | 13 | $148 |
| Sertraline Hcl | 31 | $135 |
| Clonazepam | 35 | $106 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonInvega Sustenna | $3,406 | $38,79813 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,385 psychiatric/mental health providers in New York.
Other psychiatric/mental health in Brooklyn
- Ellen KudrowBrooklyn$12K
- Rosemary FordjourBrooklyn$12K
- Tiffany LawsonBrooklyn$11K
- Tammy RussoNiskayuna$568K
- Carrie EdickSchenectady$484K
- Eric SpronzCentereach$448K
- Terry Jo Brooks-DevlinTonawanda$176K
- Kevin SiewersStaten Island$155K
- Daniel BreeyearNiskayuna$149K
- Elijah StevensBinghamton$131K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.